Innospec Inc.
NASDAQ:IOSPChemicals - Specialty
+$0.08 today
- Market cap
- $1.94B
- Beta
- 0.91
- P/E (TTM)
- 18.0
- EPS (TTM)
- $4.61
- Dividend yield
- 2.15%
Volume 0.23M
Average 0.24M
IOSP EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Innospec Inc.NASDAQ: IOSP
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q2 FY2026 EPS (Diluted) of $1.25 rose 33.0% year over year, behind the +544.7% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 2.5% from the prior quarter. Over 3 fiscal years it compounded at -4.3% a year.
Context
- EPS (Diluted) increased in 2 of the last 3 fiscal years.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 2 analysts of $5.04 (+8.0%) for the fiscal year ending Dec 2026, a slowdown from the +228.9% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $1.25+2.5% QoQ
- Last fiscal yearDec 2025
- $4.67+228.9% YoY
- LTMJun 2026
- $4.9+544.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +33.0% | +142.3% | +109.3 pp |
| 1 year | +228.9% | +8.0% | -220.9 pp |
| 3-year CAGR | -4.3% | +13.0% | +17.2 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 4.67 USD
- Year-over-year change
- +228.9%
- 4-year CAGR
- +5.6%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 4.67 | +228.9% |
| FY2024 | 2024-12-31 | 1.42 | -74.5% |
| FY2023 | 2023-12-31 | 5.56 | +4.5% |
| FY2022 | 2022-12-31 | 5.32 | +41.9% |
| FY2021 | 2021-12-31 | 3.75 | — |
EPS (Diluted) vs competitors
How IOSP compares with its peers on the latest reported figures
- IOSP's LTM Jun 2026 EPS (Diluted) of $4.9 is the 3rd highest of the 10 companies compared; the peer median is $3.59.
- Its year-over-year change of +544.7% is the 3rd highest of 10, against a peer median of -8.0%.
- Over three fiscal years its annual growth of -4.3% compares with a peer median of +11.0%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $46.39 | -8.0% | +17.0% | |
| LTM Sep 2026 | $5.6 | +1220.0% | — | |
| LTM Jun 2026 | $4.9 | +544.7% | -4.3% | |
| LTM Sep 2026 | $4.12 | +3.5% | +11.0% | |
| LTM Jun 2026 | $3.85 | -45.9% | -13.6% | |
| LTM Jun 2026 | $3.59 | -53.1% | +18.5% | |
| LTM Aug 2026 | $3.59 | +1809.5% | -5.5% | |
| LTM Jun 2026 | $1.13 | +106.1% | — | |
| LTM Mar 2026 | -$1.19 | -729.8% | — | |
| LTM Sep 2026 | -$2.25 | -423.3% | — | |
| Peer median (excluding IOSP) | $3.59 | -8.0% | +11.0% | |
Competitors are the stored peer set for IOSP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.48B | 1.96B | 1.95B | 1.85B | 1.78B |
| Cost of Revenue | 1.05B | 1.38B | 1.36B | 1.3B | 1.29B |
| Gross Profit | 434.9M | 586.7M | 591.1M | 542.9M | 492.4M |
| Gross Margin | 29.3% | 29.9% | 30.3% | 29.4% | 27.7% |
| Research & Development | 37.4M | 38.7M | 41.7M | 47.8M | 51M |
| Selling, General & Admin | 267.2M | 360.7M | 387.8M | 314M | 285.1M |
| Operating Expenses | 302.8M | 399.4M | 429.5M | 365M | 336.1M |
| Depreciation & Amortization | 42.7M | 40.1M | 39.3M | 43.5M | 43.6M |
| EBITDA | 173M | 225.8M | 213.7M | 224.6M | 181.7M |
| EBITDA Margin | 11.7% | 11.5% | 11.0% | 12.2% | 10.2% |
| Operating Income | 132.1M | 187.3M | 161.6M | 177.9M | 156.3M |
| Operating Margin | 8.9% | 9.5% | 8.3% | 9.6% | 8.8% |
| Interest Income | 0 | 0 | 0 | 0 | 9.2M |
| Interest Expense | 1.5M | 1.1M | 0 | 0 | 0 |
| Other Income / Expenses | 2.3M | (2.7M) | 12.8M | (136.7M) | (18.2M) |
| Income Before Tax | 134.4M | 184.6M | 174.4M | 41.2M | 138.1M |
| Pre-Tax Margin | 9.1% | 9.4% | 8.9% | 2.2% | 7.8% |
| Income Tax Expense | 41.3M | 51.6M | 35.3M | 5.6M | 21.5M |
| Net Income | 93.1M | 133M | 139.1M | 35.6M | 116.6M |
| Net Margin | 6.3% | 6.8% | 7.1% | 1.9% | 6.6% |
| EPS (Basic) | 3.78 | 5.37 | 5.60 | 1.43 | 4.69 |
| EPS (Diluted) | 3.75 | 5.32 | 5.56 | 1.42 | 4.67 |
| Weighted Avg Shares | 24.65M | 24.79M | 24.85M | 24.93M | 24.88M |
| Weighted Avg Shares (Diluted) | 24.85M | 24.98M | 25.02M | 25.12M | 24.99M |
Innospec Inc.
NASDAQ:IOSP
Intrinsic Alpha fair value
Locked
Current Price
$78.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.